Clinical Trials Directory

Trials / Completed

CompletedNCT00435461

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,000 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

Conditions

Interventions

TypeNameDescription
DRUGFluticasone furoate and fexofenadineFluticasone furoate and fexofenadine

Timeline

Start date
2006-12-20
Primary completion
2007-02-01
Completion
2007-02-28
First posted
2007-02-15
Last updated
2018-03-07
Results posted
2018-02-05

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00435461. Inclusion in this directory is not an endorsement.

Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine (NCT00435461) · Clinical Trials Directory